MedPath

Life Molecular Imaging Ltd

πŸ‡§πŸ‡ͺBelgium
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

1

Active:0
Completed:0

Trial Phases

1 Phases

Phase 3:1

Drug Approvals

1

FDA:1

Drug Approvals

Neuraceq

Approval Date
Jan 25, 2024
FDA

Clinical Trials

Distribution across different clinical trial phases (1 trials with phase data)β€’ Click on a phase to view related trials

Phase 3
1 (100.0%)

[18F]PI-2620 Phase 3 Histopathological Study

Phase 3
Recruiting
Conditions
Alzheimer Disease
Interventions
First Posted Date
2022-12-08
Last Posted Date
2025-06-22
Lead Sponsor
Life Molecular Imaging Ltd
Target Recruit Count
200
Registration Number
NCT05641688
Locations
πŸ‡ΊπŸ‡Έ

Barrow Neurological Institute, Phoenix, Arizona, United States

πŸ‡ΊπŸ‡Έ

Banner Sun Health Research Institute, Sun City, Arizona, United States

πŸ‡ΊπŸ‡Έ

UC Los Angeles, Los Angeles, California, United States

and more 20 locations

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Β© 2025 MedPath, Inc. All rights reserved.